Torrent Pharma has been an aggressive buyer in the domestic pharmaceutical market. Torrent Pharma is ranked eighth in the Indian pharmaceuticals market and is among the Top 5 in the therapeutics segments of cardiovascular, gastrointestinal, central nervous system and vitamins minerals nutritionals. The group has revenue of more than Rs 20,000 crore. Torrent Pharma, with annual revenue of ₹8,500 crore, is the flagship company of the Torrent Group. The skincare products market in India was valued at ₹13,000 crore in 2020, growing at a compound annual rate of 11%. Its top selling brand is the Tedibar baby soap. The company has a projection of ₹300 crore revenue and ₹90 crore operating profit for the current fiscal year, said one of the people cited above.Ĭuratio operates through a network of more than 700 distributors, reaching to over 6,000 doctors across India, focusing on dermatologists, paediatricians and gynaecologists. Curatio posted revenue of ₹240 crore in fiscal 2022 with an operating profit of ₹60 crore. As an early-stage investor, Fulcrum had acquired a majority stake in Curatio in 2005. Curatio was set up in 2005 by a team of former executives of American Remedies, including K Ramanathan and Ramani, after their company was merged with Dr Reddy's in 1999.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |